STRM.BIO
PrivateLast Round
Series 2
Jan 7, 2026
Total Funding Raised
$18.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
STRM.BIO is a biotechnology company that is developing a proprietary extracellular vesicle (EV) platform to deliver gene therapies directly to patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
STRM.BIO Comparables
Compare STRM.BIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carmine Therapeutics | 85% | |
| Neucore Bio | 80% | |
| Code Biotherapeutics | 80% |
STRM.BIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series 2 | Jan 7, 2026 | ||||
| Grant | Dec 3, 2025 | ||||
| Grant | Oct 3, 2023 | ||||
| Grant | Jul 26, 2022 | ||||
| Seed | Mar 31, 2021 |
Key People
Founding team and executive leadership
STRM.BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Seed |
| The Engine | Seed |
| NIH RADx | Grant |
| Gaingels | Seed |
| Alix Ventures | Seed |
| Gates Foundation | Grant |
| Breakout Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Raised $8M led by Recordati SpA.
- Dec 3, 2025
Awarded contract from ARPA-H for non-viral delivery technologies.
STRM.BIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about STRM.BIO's valuation, stock price, and market status.
Is STRM.BIO a public or private company?
STRM.BIO is a private company.
What is the current stock price of STRM.BIO?
STRM.BIO is a private company with no public stock price. No recent secondary market data is available.
How much is STRM.BIO worth (valuation)?
Valuation information for STRM.BIO is not publicly available.
Can I buy STRM.BIO stock?
STRM.BIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was STRM.BIO's last funding round?
STRM.BIO's most recent funding round was Series Seed 2 on December 1, 2025.
Who are the main investors in STRM.BIO?
Key investors in STRM.BIO include Ascension Ventures, The Engine, Gaingels, Alix Ventures, Breakout Ventures.
Will STRM.BIO IPO soon?
No public IPO plans have been announced for STRM.BIO.
How can I track STRM.BIO secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor STRM.BIO's secondary market activity and sign up for updates.